<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Vasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Ann Vasc Surg</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Annals of vascular surgery</journal-title></journal-title-group><issn pub-type="ppub">0890-5096</issn><issn pub-type="epub">1615-5947</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10957297</article-id><article-id pub-id-type="pmcid-ver">PMC10957297.1</article-id><article-id pub-id-type="pmcaid">10957297</article-id><article-id pub-id-type="pmcaiid">10957297</article-id><article-id pub-id-type="manuscript-id">NIHMS1959564</article-id><article-id pub-id-type="pmid">37914071</article-id><article-id pub-id-type="doi">10.1016/j.avsg.2023.08.031</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1959564</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1959564</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Carotid Endarterectomy Should Not Be Recommended to End-Stage Kidney Disease Patients with Asymptomatic Carotid Artery Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Hafeez</surname><given-names initials="MS">Muhammad Saad</given-names></name><degrees>MBBS</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Abdul-Malak</surname><given-names initials="O">Othman</given-names></name><degrees>MD MS</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Eslami</surname><given-names initials="MH">Mohammad H</given-names></name><degrees>MD MPH</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chaer</surname><given-names initials="RA">Rabih A</given-names></name><degrees>MD MS</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yuo</surname><given-names initials="TH">Theodore H</given-names></name><degrees>MD MSc</degrees><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1-</label> Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA</aff><author-notes><corresp id="CR1"><bold>Corresponding Author:</bold> Muhammad Saad Hafeez MBBS, 200 Lothtrop Street, Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, <email>saad.hafeez@alumni.aku.edu</email>, Phone Number: +1-412-626-4704</corresp><corresp id="CR2"><bold>Post-Publication Corresponding Author:</bold> Theodore H Yuo MD MS, 200 Lothtrop Street, Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, <email>yuoth@upmc.edu</email>, Phone Number:</corresp><fn fn-type="COI-statement" id="FN2"><p id="P37"><bold>Declaration of Conflicting Interests:</bold> The authors declare that there is no conflict of interest.</p></fn></author-notes><pub-date pub-type="ppub"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>31</day><month>10</month><year>2023</year></pub-date><volume>101</volume><issue-id pub-id-type="pmc-issue-id">458375</issue-id><fpage>53</fpage><lpage>61</lpage><pub-history><event event-type="nihms-submitted"><date><day>16</day><month>01</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>04</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 18:25:27.997"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1959564.pdf"/><abstract id="ABS1"><sec id="S1"><title>Introduction:</title><p id="P1">Carotid endarterectomy (CEA) for asymptomatic carotid artery disease is advised for patients with low perioperative stroke risk and life expectancy of three to five years. We sought to explore the role of risk stratification and postoperative medical management in identifying appropriate asymptomatic candidates for CEA in the end-stage kidney disease (ESKD) population.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">We identified ESKD patients on dialysis from the United States Renal Data System (USRDS) that underwent CEA (2008 &#8211; 2014) for asymptomatic carotid artery disease. We used the Liu comorbidity index as well as a novel risk prediction model based on Cox-proportional hazards model to stratify patients. The primary outcome evaluated was three-year survival, and Kaplan-Meier methods were used to generate survival estimates.</p><p id="P3">We further conducted a sub-analysis of patients with Medicare part D data to determine postoperative usage of the following medications: statins, antiplatelets, and antihypertensives. We evaluated the association of medication utilization and three-year survival using Kaplan-Meier methods and Cox proportional hazards modelling.</p></sec><sec id="S3"><title>Results:</title><p id="P4">We analyzed 1,813 patients meeting inclusion criteria. The population was predominantly older (mean age 70.2&#177;9.1), White (84.8%) and had a high prevalence of cardiovascular comorbidities, such as hypertension (90.7%), diabetes (62.5%) and CHF (35.4%). Among the entire cohort, 23.0% had a Liu comorbidity index &#8804; 8, 35.0% had index 9 to 12, and 42.0% had index &gt;12. Increasing Liu comorbidity index was associated with worse survival (p&lt;0.01), however even the group with Liu index &#8804; 8 had poor three-year survival of 58.8 (53.9 &#8211; 63.4) %.</p><p id="P5">The Cox proportional hazards model identified variables for inclusion in the risk model such as age&gt;80 (aHR=2.49, 95% CI [1.87-3.33], p&lt;0.001), congestive heart failure (aHR=1.31, 95% CI [1.14-1.51], p&lt;0.001) and Liu comorbidity index &gt; 12 (aHR=1.89, 95% C.I. [1.56 &#8211; 2.28], p&lt;0.001). The risk score generated ranged from 0 to 6.5, and patients were divided into three groups: score &#8804;2 (43.4%), 2 to 4 (41.2%), and &gt;4 (15.4%). Increasing risk score was associated with worse survival (p&lt;0.01) but even the &#8220;low-risk&#8221; group had three-year survival of 58.5 (54.9 &#8211; 61.9)%.</p><p id="P6">Sub-analysis of the 1,249 (68.8% of total) patients with part D data found that statins and calcium channel blocker use was associated with improved survival, although observed rates for patients on drug were still low.</p></sec><sec id="S4"><title>Conclusion:</title><p id="P7">The overall long-term survival of ESKD patients undergoing CEA for asymptomatic carotid artery disease is low. Risk stratification and analysis of postoperative medical management did not identify a subgroup of patients with adequate three-year survival. Hence, the preventive benefits of CEA are not realized in these patients.</p></sec></abstract><kwd-group><kwd>dialysis</kwd><kwd>database</kwd><kwd>carotid endarterectomy</kwd><kwd>outcomes</kwd><kwd>medical management</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>